Mannkind reported $366.99M in Loan Capital for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Chemocentryx CCXI:US $ 4M 0.55M
Dynavax Technologies DVAX:US $ 221.03M 0.27M
Eli Lilly And LLY:US $ 14692M 460.9M
Halozyme Therapeutics HALO:US $ 1147.13M 359.03M
Insmed INSM:US $ 807.11M 447K
JAZZ PHA JAZZ:US $ 5990M 2.87M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Macrogenics MGNX:US $ 0 0
Mannkind MNKD:US $ 366.99M 8.14M
Novo Nordisk A Fs NVO:US $ 24178M 94M
Peregrine Pharmaceuticals PPHM:US $ 141.67M 0.14M
Xencor XNCR:US $ 0M 0M